Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

Item
http://www.wikidata.org/entity/Q59154932
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.The frequency of occurrence of atypical lymphocytes in peripheral blood smears of natalizumab-treated patients with multiple sclerosis.Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
P2860

Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

Item
http://www.wikidata.org/entity/Q59154932
description
im Juni 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2014
@uk
name
Long-term follow-up of periphe ...... ients treated with natalizumab
@en
Long-term follow-up of periphe ...... ients treated with natalizumab
@nl
type
label
Long-term follow-up of periphe ...... ients treated with natalizumab
@en
Long-term follow-up of periphe ...... ients treated with natalizumab
@nl
prefLabel
Long-term follow-up of periphe ...... ients treated with natalizumab
@en
Long-term follow-up of periphe ...... ients treated with natalizumab
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Long-term follow-up of periphe ...... ients treated with natalizumab
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932